ScholarIQanswers from OpenAlex & ORCID
David R. Holmes
ResearcherPublications, citations & collaboration network
David R. Holmes is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does David R. Holmes have?
ScholarIQindexed works
David R. Holmes has 2,070 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does David R. Holmes have?
ScholarIQcitation count
David R. Holmes has 139,201 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of David R. Holmes?
ScholarIQh-index
David R. Holmes has an h-index of 177 in OpenAlex.
What is the i10-index of David R. Holmes?
ScholarIQi10-index
David R. Holmes has an i10-index of 1,101 in OpenAlex.
What is the ORCID of David R. Holmes?
ScholarIQorcid
The ORCID for David R. Holmes is on the source record.
What is the OpenAlex record for David R. Holmes?
ScholarIQopenalex
The OpenAlex for David R. Holmes is on the source record.
What are the most-cited papers on David R. Holmes?
ScholarIQmost cited works
Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery
Jeffrey W. Moses, Martin B. Leon, Jeffrey J. Popma, Peter J. Fitzgerald, David R. Holmes, Charles O’Shaughnessy, Ronald Caputo, Dean J. Kereiakes, David O. Williams, Paul S. Teirstein, Judith Jaeger, Richard E. Kuntz
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
Ezra A. Amsterdam, Nanette K. Wenger, Ralph G. Brindis, Donald E. Casey, Théodore G. Ganiats, David R. Holmes, Allan S. Jaffe, Hani Jneid, Rosemary F. Kelly, Michael C. Kontos, Glenn N. Levine, Philip R. Liebson, Debabrata Mukherjee, Eric D. Peterson, Marc S. Sabatine, Richard W. Smalling, Susan J. Zieman
Long-Term Follow-Up of Patients With Mild Coronary Artery Disease and Endothelial Dysfunction
Jassim Al Suwaidi, Shuichi Hamasaki, Stuart T. Higano, Rick A. Nishimura, David R. Holmes, Amir Lerman
Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents
Laura Mauri, Dean J. Kereiakes, Robert W. Yeh, Priscilla Driscoll-Shempp, Donald E. Cutlip, Philippe Gabríel Steg, Sharon‐Lise T. Normand, Eugene Braunwald, Stephen D. Wiviott, David J. Cohen, David R. Holmes, Mitchell W. Krucoff, James Hermiller, Harold L. Dauerman, Daniel I. Simon, David E. Kandzari, Kirk N. Garratt, David P. Lee, Thomas Pow, Peter Ver Lee, Michael J. Rinaldi, Joseph M. Massaro
Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II
Vasim Farooq, David van Klaveren, Ewout W. Steyerberg, Emanuele Meliga, Yvonne Vergouwe, Alaide Chieffo, A. Pieter Kappetein, Antonio Colombo, David R. Holmes, Michael J. Mack, Ted Feldman, Marie-Claude Morice, Elisabeth Ståhle, Yoshinobu Onuma, Marie-angèle Morel, Héctor M. García‐García, Gerrit Anne van Es, Keith D. Dawkins, Friedrich W. Mohr, Patrick W. Serruys